SCHEMBL16475166

SCHEMBL16475166

[O-][n+]1cc(Br)c2cnn(Cc3ccccc3)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.49
HPGD P15428 5/20 0.41
ALDH1A1 P00352 5/20 0.41
PKM P14618 4/20 0.41
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
GRM2 Q14416 1/20 0.40
MAPT P10636 3/20 0.40
TSHR P16473 1/20 0.40
BRD4 O60885 1/20 0.39
HSD17B10 Q99714 2/20 0.39
HTT P42858 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPK1 P28482 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1169734 0.77 RECQL (0.60) RECQLHPGDALDH1A1PKMLMNA
SCHEMBL16475156 0.76 RECQL (0.54) RECQLHPGDALDH1A1PKMLMNA
SCHEMBL9941798 0.72 RECQL (0.50) RECQLHPGDALDH1A1PKMLMNA
SCHEMBL4792406 0.68 RECQL (0.60) RECQLHPGDALDH1A1PKMLMNA
SCHEMBL1169685 0.68 RECQL (0.60) RECQLHPGDALDH1A1PKMLMNA
SCHEMBL17397366 0.67 TSHR (0.56) RECQLHPGDALDH1A1PKMLMNA
SCHEMBL18164294 0.67 RECQL (0.43) RECQLALDH1A1PKMLMNAMAPT
SCHEMBL1172524 0.67 RECQL (0.58) RECQLHPGDALDH1A1PKMLMNA
SCHEMBL29279390 0.67 RECQL (0.47) RECQLHPGDALDH1A1PKMLMNA
SCHEMBL30346162 0.66 RECQL (1.00) RECQLALDH1A1GRM2TSHRBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180064692-A1 Anti-Fibrotic Pyridinones GENENTECH, INC. 2018-03-08 US disclosed
US-9675593-B2 Anti-fibrotic pyridinones INTERMUNE, INC. (US) 2017-06-13 US disclosed
US-20170121345-A1 ANTI-FIBROTIC PYRIDINONES GENENTECH, INC. 2017-05-04 US disclosed
US-20160263090-A1 ANTI-FIBROTIC PYRIDINONES GENENTECH, INC. 2016-09-15 US disclosed
US-9359379-B2 Anti-fibrotic pyridinones INTERMUNE, INC. (US) 2016-06-07 US disclosed
US-9359379-B2 Anti-fibrotic pyridinones INTERMUNE, INC. (US) 2016-06-07 US disclosed
WO-2015153683-A1 ANTI-FIBROTIC PYRIDINONES INTERMUNE, INC. (US) 2015-10-08 WO disclosed
US-20140107110-A1 ANTI-FIBROTIC PYRIDINONES GENENTECH, INC. 2014-04-17 US disclosed
US-20140107110-A1 ANTI-FIBROTIC PYRIDINONES GENENTECH, INC. 2014-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180064692-A1 Anti-Fibrotic Pyridinones MMP1, COL1A1, COL2A1 RECQL 1331/4885HPGD 298/4885ALDH1A1 529/4885
US-20140107110-A1 ANTI-FIBROTIC PYRIDINONES MMP1, COL1A1, COL2A1 RECQL 1331/4885HPGD 298/4885ALDH1A1 529/4885
US-20160263090-A1 ANTI-FIBROTIC PYRIDINONES MMP1, COL1A1, COL2A1 RECQL 1331/4885HPGD 298/4885ALDH1A1 529/4885
US-20170121345-A1 ANTI-FIBROTIC PYRIDINONES MMP1, COL1A1, COL2A1 RECQL 1331/4885HPGD 298/4885ALDH1A1 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.